Bank of New York Mellon Corp acquired a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 13,599 shares of the company's stock, valued at approximately $276,000.
A number of other large investors have also bought and sold shares of GRDN. Wellington Management Group LLP bought a new stake in shares of Guardian Pharmacy Services in the third quarter valued at about $8,400,000. Franklin Resources Inc. bought a new stake in Guardian Pharmacy Services in the 3rd quarter valued at approximately $8,575,000. Barclays PLC acquired a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $311,000. Maven Securities LTD bought a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $3,033,000. Finally, Rhumbline Advisers acquired a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at approximately $149,000.
Guardian Pharmacy Services Trading Up 2.7 %
GRDN traded up $0.56 during trading hours on Wednesday, hitting $21.57. 56,224 shares of the company's stock were exchanged, compared to its average volume of 157,890. Guardian Pharmacy Services, Inc. has a 1-year low of $14.16 and a 1-year high of $25.74. The firm has a 50-day moving average price of $20.56.
Guardian Pharmacy Services Profile
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
